Identification of Limiting Factors in the Locomotor Activity of Individuals With Lower Limb Amputation:
AMPUTEEFACT
2 other identifiers
observational
200
0 countries
N/A
Brief Summary
The experience of amputation leads to a deterioration in quality of life, with undeniable somatic and functional repercussions. The result is a reduction in general mobility, increased metabolic energy requirements and a feeling of discomfort and pain. The rehabilitation objectives focus on improving, or at least maintaining, the range of movement of the lower limbs, strengthening the overall muscles, ensuring that the equipment is correctly adapted, re-training for physical exertion and working on balance and walking. The rehabilitation objectives focus on social inclusion with the equipment, to optimise the return home and promote social and professional reintegration, and therapeutic education. Factors influencing the postoperative resumption of walking in amputees have been identified as key elements in the success of rehabilitation management. These include maintaining joint range of motion before fitting any equipment, combating postoperative loss of muscle mass, managing cardiorespiratory deconditioning and, finally, resuming walking with the aid of equipment, taking account of fluctuating balance. The literature shows that a change in the centre of gravity and postural instability, particularly when changing stance, are responsible for a greater risk of falls in lower-limb amputees. This asymmetry of gait, which is the cause of a greater risk of secondary joint degeneration, is found in both transtibial and transfemoral amputees. This alteration in balance has a direct influence on walking ability, and therefore calls for significant proprioceptive management in the rehabilitation programme. Gait analysis in lower-limb amputees therefore seems essential, both for the purposes of evaluating and monitoring rehabilitation treatment, and for prosthetic selection and adjustment. Three-dimensional assessment of walking in amputees, coupled with force platforms, is the test of choice for providing kinematic, kinetic and spatiotemporal data (motion capture).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 7, 2025
January 1, 2025
9 months
May 13, 2024
January 6, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
VO2 consumption as a function of amputation level
To quantify the cost (consumption of Vo2 in mL/kg/min) of a task as a function of the level of amputation. VO2 consumption is measured using a VO2 master calorimetric mask, which analyses gas exchange for 3 minutes. To quantify the cost of the task, VO2 consumption over the 3rd minute is used, normalised in relation to VO2 consumption at rest.
Before and during performance of a standardised motor task
VO2 consumption as a function of gait asymmetry
Quantify the cost (Vo2 consumption in mL/kg/min) of a task as a function of gait asymmetry compared with VO2 consumption at rest.
Before and during performance of a standardised motor task
Consumption of VO2 as a function of prosthetic equipment
To quantify the cost (consumption of Vo2 in mL/kg/min) of a task as a function of the prosthetic equipment compared with the consumption of VO2 at rest.
Before and during performance of a standardised motor task
Consumption of VO2 as a function of walking condition.
To quantify the cost (consumption of Vo2 in mL/kg/min) of a task as a function of the walking condition compared with the consumption of VO2 at rest.
Before and during performance of a standardised motor task
Study Arms (1)
Lower Limb Amputation
Patients with lower limb amputations, unilateral or bilateral, walking with or without technical aids, at any level (trans-femoral or trans-tibial) and hospitalised in the locomotor rehabilitation department of the Nîmes University Hospital.
Interventions
Eligibility Criteria
Patients with lower limb amputations, unilateral or bilateral, walking with or without technical aids, whatever the level (trans-femoral or trans-tibial) and hospitalised in the locomotor rehabilitation department. Patients who were not autonomous enough to walk and required a third person (human aid) were not included.
You may qualify if:
- Amputees in PRM hospitalisation at the CHU Nîmes RRL service University Rehabilitation Hospital in Le Grau du Roi.
- All aetiologies: vascular, traumatic and septic.
- Appropriate vascular equipment validated by PRM doctor.
- Able to walk for 5 minutes on a treadmill.
- Patient affiliated to or benefiting from a health insurance scheme.
- Adult patient (\>18 years) and under 80 years of age.
You may not qualify if:
- Patients with uncorrected or untreated visual disorders.
- Patients with major cognitive impairment (MOCA\>23).
- Patients with vestibular disorders.
- Patient with uncontrolled epilepsy.
- Patient with an unhealed amputation stump.
- Weight \> 135kg or \< 20kg
- Patients with a FAC of 1 (i.e. patients requiring the firm and continuous assistance of another person to carry their weight and maintain their balance) or less.
- Inability to properly adjust the sling to the corresponding body part due to:
- Body shape
- Colostomy bags
- Skin lesions that cannot be adequately protected.
- Any other reason that prevents the harness from being adjusted correctly and painlessly.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Anissa MEGZARI
Centre Hospitalier Universitaire de Nīmes
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2024
First Posted
May 16, 2024
Study Start
March 1, 2025
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
January 7, 2025
Record last verified: 2025-01